These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7743513)
1. Cytoplasmic localization of a mutant M(r) 160,000 topoisomerase II alpha is associated with the loss of putative bipartite nuclear localization signals in a drug-resistant human lung cancer cell line. Mirski SE; Cole SP Cancer Res; 1995 May; 55(10):2129-34. PubMed ID: 7743513 [TBL] [Abstract][Full Text] [Related]
2. Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing. Yu Q; Mirski SE; Sparks KE; Cole SP Biochemistry; 1997 May; 36(19):5868-77. PubMed ID: 9153428 [TBL] [Abstract][Full Text] [Related]
3. Altered subcellular distribution of topoisomerase II alpha in a drug-resistant human small cell lung cancer cell line. Feldhoff PW; Mirski SE; Cole SP; Sullivan DM Cancer Res; 1994 Feb; 54(3):756-62. PubMed ID: 8306338 [TBL] [Abstract][Full Text] [Related]
4. Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16. Mirski SE; Evans CD; Almquist KC; Slovak ML; Cole SP Cancer Res; 1993 Oct; 53(20):4866-73. PubMed ID: 8104687 [TBL] [Abstract][Full Text] [Related]
5. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line. Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479 [TBL] [Abstract][Full Text] [Related]
6. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone. Harker WG; Slade DL; Parr RL; Holguin MH Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537 [TBL] [Abstract][Full Text] [Related]
7. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay. Withoff S; Smit EF; Meersma GJ; van den Berg A; Timmer-Bosscha H; Kok K; Postmus PE; Mulder NH; de Vries EG; Buys CH Lab Invest; 1994 Jul; 71(1):61-6. PubMed ID: 8041119 [TBL] [Abstract][Full Text] [Related]
8. Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells. Danks MK; Warmoth MR; Friche E; Granzen B; Bugg BY; Harker WG; Zwelling LA; Futscher BW; Suttle DP; Beck WT Cancer Res; 1993 Mar; 53(6):1373-9. PubMed ID: 8383009 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin. Jain N; Lam YM; Pym J; Campling BG Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a DNA topoisomerase IIalpha gene rearrangement in adriamycin-resistant P388 leukemia: expression of a fusion messenger RNA transcript encoding topoisomerase IIalpha and the retinoic acid receptor alpha locus. McPherson JP; Brown GA; Goldenberg GJ Cancer Res; 1993 Dec; 53(24):5885-9. PubMed ID: 8261398 [TBL] [Abstract][Full Text] [Related]
11. Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization. Wessel I; Jensen PB; Falck J; Mirski SE; Cole SP; Sehested M Cancer Res; 1997 Oct; 57(20):4451-4. PubMed ID: 9377550 [TBL] [Abstract][Full Text] [Related]
12. Heterogeneous expression of DNA topoisomerase II alpha isoforms in tumor cell lines. Mo YY; Beck WT Oncol Res; 1997; 9(4):193-204. PubMed ID: 9268990 [TBL] [Abstract][Full Text] [Related]
13. Bipartite nuclear localization signals in the C terminus of human topoisomerase II alpha. Mirski SE; Gerlach JH; Cummings HJ; Zirngibl R; Greer PA; Cole SP Exp Cell Res; 1997 Dec; 237(2):452-5. PubMed ID: 9434641 [TBL] [Abstract][Full Text] [Related]
14. A truncated cytoplasmic topoisomerase IIalpha in a drug-resistant lung cancer cell line is encoded by a TOP2A allele with a partial deletion of exon 34. Mirski SE; Sparks KE; Yu Q; Lang AJ; Jain N; Campling BG; Cole SP Int J Cancer; 2000 Feb; 85(4):534-9. PubMed ID: 10699927 [TBL] [Abstract][Full Text] [Related]
15. A novel point mutation in the 3' flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agents. Hashimoto S; Danks MK; Chatterjee S; Beck WT; Berger NA Oncol Res; 1995; 7(1):21-9. PubMed ID: 7549041 [TBL] [Abstract][Full Text] [Related]
16. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II. Cole SP; Chanda ER; Dicke FP; Gerlach JH; Mirski SE Cancer Res; 1991 Jul; 51(13):3345-52. PubMed ID: 1675932 [TBL] [Abstract][Full Text] [Related]
17. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin. Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812 [TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202 [TBL] [Abstract][Full Text] [Related]
19. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines. Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249 [TBL] [Abstract][Full Text] [Related]
20. Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection. Andoh T; Nishizawa M; Hida T; Ariyoshi Y; Takahashi T; Ueda R Oncol Res; 1996; 8(6):229-38. PubMed ID: 8895198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]